ChickenStockChickenStock

AI English summary of an SEC filing — figures as filed

Universal Health Services logoUniversal Health Services UHS

The company said net income attributable to UHS was $261.8 million ($3.82 per diluted share) in Q1 2024, and net revenues rose 10.8% to $3.844 billion. For Q1 2023, net income attributable to UHS was $163.1 million and net revenues were $3.468 billion.

8-KResults of Operations and Financial ConditionFiled Period of report Summary published (UTC)

Key points

AI summary
  1. The company said net income attributable to UHS was $261.8 million ($3.82 per diluted share) in Q1 2024, and net revenues rose 10.8% to $3.844 billion. For Q1 2023, net income attributable to UHS was $163.1 million and net revenues were $3.468 billion.

  2. The company said net cash provided by operating activities for Q1 2024 was $396 million, up $106 million from $291 million for Q1 2023. As of March 31, 2024, aggregate available borrowing capacity under its $1.2 billion revolving credit facility was $733 million.

  3. The company said it repurchased 700,000 shares for about $125.1 million (about $179 per share) during Q1 2024 and that, as of March 31, its remaining repurchase authorization was about $298 million. It also disclosed a jury verdict against The Pavilion on March 28 awarding compensatory damages of $60 million and punitive damages of $475 million.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call. Some paragraphs were omitted because their support in the source could not be confirmed.

UHS Net Income Attributable to UHS and Net Revenues for Q1 2024

The company said net income attributable to UHS was $261.8 million ($3.82 per diluted share) in Q1 2024, and net revenues rose 10.8% to $3.844 billion. For Q1 2023, net income attributable to UHS was $163.1 million and net revenues were $3.468 billion.

Source · Based on the filing body and exhibits

Operating Cash Flow and Liquidity

The company said net cash provided by operating activities for Q1 2024 was $396 million, up $106 million from $291 million for Q1 2023. As of March 31, 2024, aggregate available borrowing capacity under its $1.2 billion revolving credit facility was $733 million.

Source · Based on the filing body and exhibits

Share Repurchases and Pavilion Jury Verdict

The company said it repurchased 700,000 shares for about $125.1 million (about $179 per share) during Q1 2024 and that, as of March 31, its remaining repurchase authorization was about $298 million. It also disclosed a jury verdict against The Pavilion on March 28 awarding compensatory damages of $60 million and punitive damages of $475 million.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.